多重耐药肺炎克雷伯菌噬菌体耐药性的产生与毒力降低相关:一例个体化噬菌体治疗的病例报告
一例多重耐药肺炎克雷伯菌肺部感染患者接受两程噬菌体治疗,第二程后出现噬菌体耐药菌株。全基因组分析显示耐药株fabF缺失导致脂多糖结构改变,小鼠和斑马鱼模型显示耐药株毒力降低。
要点
- 第二程噬菌体治疗后出现噬菌体耐药肺炎克雷伯菌株。
- 耐药株fabF缺失导致脂多糖结构改变,脂多糖为治疗噬菌体的宿主受体。
- 小鼠和斑马鱼模型显示耐药株毒力降低。
核心结论
- 本研究可能揭示部分患者噬菌体治疗后症状临床改善而病原菌未被完全清除的机制。
研究设计与样本
- 一例多重耐药肺炎克雷伯菌肺部感染住院患者接受个体化噬菌体治疗的病例报告。
- 患者先接受单种雾化噬菌体ΦKp_GWPB35针对其分离菌Kp7450的第一程治疗,14天后接受噬菌体鸡尾酒ΦKp_GWPB35+ΦKp_GWPA139的第二程治疗。
- 噬菌体治疗全程继续抗生素治疗。
- 采用全基因组分析鉴定噬菌体耐药株的突变,通过构建Kp7450敲除株及测定蛋白酶K和高碘酸盐处理细菌的噬菌体吸附率分析耐药相关突变基因。
- 采用小鼠和斑马鱼感染模型评估细菌毒力。
主要发现
- 第二程噬菌体治疗后出现噬菌体耐药肺炎克雷伯菌株。
- 比较基因组分析显示噬菌体耐药株中fabF缺失。
- fabF敲除株Kp7450ΔfabF导致脂多糖结构改变,脂多糖被鉴定为治疗噬菌体的宿主受体。
- 小鼠和斑马鱼模型毒力评估显示脂多糖是Kp7450毒力的主要决定因素,Kp7450ΔfabF中脂多糖结构改变及噬菌体耐药株以代价方式降低毒力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Phage-resistant bacteria often emerge rapidly when performing phage therapy. However, the relationship between the emergence of phage-resistant bacteria and improvements in clinical symptoms is still poorly understood. METHODS: An inpatient developed a pulmonary infection caused by multidrug-resistant Klebsiella pneumoniae. He received a first course of treatment with a single nebulized phage (ΦKp_GWPB35) targeted at his bacterial isolate of Kp7450. After 14 days, he received a second course of treatment with a phage cocktail (ΦKp_GWPB35+ΦKp_GWPA139). Antibiotic treatment was continued throughout the course of phage therapy. Whole-genome analysis was used to identify mutations in phage-resistant strains. Mutated genes associated with resistance were further analysed by generating knockouts of Kp7450 and by measuring phage adsorption rates of bacteria treated with proteinase K and periodate. Bacterial virulence was evaluated in mouse and zebrafish infection models. RESULTS: Phage-resistant Klebsiella pneumoniae strains emerged after the second phage treatment. Comparative genomic analyses revealed that fabF was deleted in phage-resistant strains. The fabF knockout strain (Kp7450ΔfabF) resulted in an altered structure of lipopolysaccharide (LPS), which was identified as the host receptor for the therapeutic phages. Virulence evaluations in mice and zebrafish models showed that LPS was the main determinant of virulence in Kp7450 and alteration of LPS structure in Kp7450ΔfabF, and the bacteriophage-resistant strains reduced their virulence at cost. DISCUSSION: This study may shed light on the mechanism by which some patients experience clinical improvement in their symptoms post phage therapy, despite the incomplete elimination of pathogenic bacteria.
引用
- Li J, Yan B, He B, et al. Development of phage resistance in multidrug-resistant Klebsiella pneumoniae is associated with reduced virulence: a case report of a personalised phage therapy. Clin Microbiol Infect. 2023. PMID: 37652124. doi:10.1016/j.cmi.2023.08.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。